COVID-19 and cardiac considerations in the community

Br J Gen Pract. 2020 Oct 29;70(700):524-525. doi: 10.3399/bjgp20X713141. Print 2020 Nov.

Authors

Christine A'Court¹, Mayooran Shanmuganathan², Juan Carlos Leoni-Moreno³

Affiliations

¹ Integrated Cardiology Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
² Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
³ Department of Transplant, Mayo Clinic, Jacksonville, FL, US.

No abstract available

Publication types

Editorial

MeSH terms

Aftercare / methods*
Betacoronavirus
COVID-19
Comorbidity
Convalescence
Coronavirus Infections* / epidemiology
Coronavirus Infections* / physiopathology
Coronavirus Infections* / rehabilitation
Echocardiography / methods
Electrocardiography / methods
General Practice / methods*
Heart Diseases* / blood
Heart Diseases* / diagnosis
Heart Diseases* / therapy
Heart Diseases* / virology
Humans
Magnetic Resonance Imaging, Cine / methods
Natriuretic Peptide, Brain / blood
Pandemics*
Patient Acuity
Peptide Fragments / blood
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / physiopathology
Pneumonia, Viral* / rehabilitation
Recovery of Function
SARS-CoV-2
Symptom Assessment / methods
Troponin / blood

Substances

Peptide Fragments
Troponin
pro-brain natriuretic peptide (1-76)
Natriuretic Peptide, Brain